Susquehanna International Group’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.89M | Sell |
45,200
-239,400
| -84% | -$21.5M | ﹤0.01% | 4724 |
|
|
2025
Q4 | $24.8M | Buy |
284,600
+275,700
| +3,098% | +$20.9M | ﹤0.01% | 1991 |
|
|
2025
Q3 | $510K | Sell |
8,900
-66,300
| -88% | -$3.82M | ﹤0.01% | 8907 |
|
|
2025
Q2 | $4.44M | Buy |
75,200
+36,300
| +93% | +$2.35M | ﹤0.01% | 4194 |
|
|
2025
Q1 | $2.85M | Sell |
38,900
-78,400
| -67% | -$6.48M | ﹤0.01% | 4758 |
|
|
2024
Q4 | $9.7M | Sell |
117,300
-2,300
| -2% | -$181K | ﹤0.01% | 2704 |
|
|
2024
Q3 | $8.56M | Buy |
119,600
+35,700
| +43% | +$2.52M | ﹤0.01% | 2827 |
|
|
2024
Q2 | $5.75M | Sell |
83,900
-19,400
| -19% | -$1.16M | ﹤0.01% | 3225 |
|
|
2024
Q1 | $5.54M | Buy |
103,300
+6,700
| +7% | +$360K | ﹤0.01% | 3475 |
|
|
2023
Q4 | $5.15M | Sell |
96,600
-42,200
| -30% | -$2.06M | ﹤0.01% | 3652 |
|
|
2023
Q3 | $6.89M | Sell |
138,800
-22,700
| -14% | -$1.27M | ﹤0.01% | 3042 |
|
|
2023
Q2 | $9.62M | Sell |
161,500
-29,600
| -15% | -$1.69M | ﹤0.01% | 2548 |
|
|
2023
Q1 | $10.8M | Buy |
191,100
+148,000
| +343% | +$9.49M | ﹤0.01% | 2336 |
|
|
2022
Q4 | $3.2M | Sell |
43,100
-20,700
| -32% | -$1.41M | ﹤0.01% | 3908 |
|
|
2022
Q3 | $3.8M | Buy |
63,800
+2,200
| +4% | +$132K | ﹤0.01% | 3613 |
|
|
2022
Q2 | $3.46M | Sell |
61,600
-58,100
| -49% | -$3.82M | ﹤0.01% | 3819 |
|
|
2022
Q1 | $8.83M | Sell |
119,700
-15,800
| -12% | -$1.1M | ﹤0.01% | 2720 |
|
|
2021
Q4 | $9.78M | Buy |
135,500
+25,700
| +23% | +$1.87M | ﹤0.01% | 2746 |
|
|
2021
Q3 | $8.41M | Sell |
109,800
-21,500
| -16% | -$1.73M | ﹤0.01% | 3126 |
|
|
2021
Q2 | $10.2M | Buy |
131,300
+49,900
| +61% | +$3.55M | ﹤0.01% | 2899 |
|
|
2021
Q1 | $5.02M | Buy |
81,400
+15,200
| +23% | +$963K | ﹤0.01% | 3908 |
|
|
2020
Q4 | $4.32M | Sell |
66,200
-69,400
| -51% | -$3.99M | ﹤0.01% | 3661 |
|
|
2020
Q3 | $6.71M | Buy |
135,600
+43,200
| +47% | +$2.23M | ﹤0.01% | 2704 |
|
|
2020
Q2 | $4.41M | Sell |
92,400
-29,700
| -24% | -$1.43M | ﹤0.01% | 3178 |
|
|
2020
Q1 | $5.19M | Buy |
122,100
+61,800
| +102% | +$3.05M | ﹤0.01% | 2522 |
|
|
2019
Q4 | $3.55M | Buy |
60,300
+34,500
| +134% | +$1.87M | ﹤0.01% | 3447 |
|
|
2019
Q3 | $1.32M | Sell |
25,800
-3,300
| -11% | -$157K | ﹤0.01% | 5101 |
|
|
2019
Q2 | $1.23M | Sell |
29,100
-30,700
| -51% | -$1.33M | ﹤0.01% | 5196 |
|
|
2019
Q1 | $2.96M | Buy |
59,800
+22,100
| +59% | +$1,000K | ﹤0.01% | 3153 |
|
|
2018
Q4 | $1.63M | Sell |
37,700
-45,800
| -55% | -$2.29M | ﹤0.01% | 3827 |
|
|
2018
Q3 | $4.74M | Buy |
83,500
+13,100
| +19% | +$689K | ﹤0.01% | 2761 |
|
|
2018
Q2 | $3.55M | Buy |
70,400
+58,200
| +477% | +$3.03M | ﹤0.01% | 3159 |
|
|
2018
Q1 | $608K | Sell |
12,200
-75,600
| -86% | -$3.55M | ﹤0.01% | 6237 |
|
|
2017
Q4 | $3.61M | Buy |
87,800
+40,900
| +87% | +$1.43M | ﹤0.01% | 2946 |
|
|
2017
Q3 | $1.39M | Buy |
+46,900
| New | +$1.43M | ﹤0.01% | 4616 |
|
|
2017
Q1 | – | Sell |
-92,200
| Closed | -$2.29M | – | 9298 |
|
|
2016
Q4 | $2.29M | Buy |
92,200
+18,700
| +25% | +$425K | ﹤0.01% | 3793 |
|
|
2016
Q3 | $1.66M | Sell |
73,500
-8,600
| -10% | -$202K | ﹤0.01% | 3869 |
|
|
2016
Q2 | $1.96M | Buy |
82,100
+50,700
| +161% | +$1.22M | ﹤0.01% | 3606 |
|
|
2016
Q1 | $746K | Buy |
31,400
+13,500
| +75% | +$330K | ﹤0.01% | 5672 |
|
|
2015
Q4 | $498K | Sell |
17,900
-26,700
| -60% | -$670K | ﹤0.01% | 6776 |
|
|
2015
Q3 | $921K | Buy |
44,600
+32,300
| +263% | +$818K | ﹤0.01% | 5934 |
|
|
2015
Q2 | $316K | Sell |
12,300
-14,900
| -55% | -$377K | ﹤0.01% | 8442 |
|
|
2015
Q1 | $687K | Buy |
27,200
+2,900
| +12% | +$70.6K | ﹤0.01% | 6514 |
|
|
2014
Q4 | $578K | Buy |
+24,300
| New | +$538K | ﹤0.01% | 6958 |
|
|
2013
Q4 | – | Sell |
-17,900
| Closed | -$313K | – | 9096 |
|
|
2013
Q3 | $313K | Buy |
17,900
+3,000
| +20% | +$51.9K | ﹤0.01% | 7144 |
|
|
2013
Q2 | $251K | Buy |
+14,900
| New | +$230K | ﹤0.01% | 7103 |
|
Other funds holding GMED
VCM
VPM
SC
Susquehanna International Group's GMED Position: Q1 2026 in Review
Susquehanna International Group increased its Globus Medical (GMED) stake by 251% in Q1 2026, buying an estimated $975K and bringing the position to 15,203 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #7214.
Susquehanna International Group first reported a position in GMED in Q4 2013 and has held it in 35 quarters since. The position peaked at $16M in Q3 2023. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Susquehanna International Group held 15,203 shares of Globus Medical worth $1.31M as of Q1 2026.
- Susquehanna International Group bought 10,868 Globus Medical shares in Q1 2026, an estimated $975K.
- Globus Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7214 holding.
- Susquehanna International Group first reported a position in Globus Medical in Q4 2013 and has held it in 35 quarters since.
- Susquehanna International Group's Globus Medical position peaked at $16M in Q3 2023.
- 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.